Physician profile
Timothy Lorenz
NPI 1811952526
$3,315.28
in general payments reported to CMS, 2019-2025
28 companies · $678 in 2025
The $678 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $162 · 2021: $56.04 · 2022: $684 · 2023: $779 · 2024: $459 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $275.03 | 2019-2024 | Caldolor |
| Csl Behring | $267.70 | 2020-2023 | Kcentra |
| Heron Therapeutics, INC. | $221.80 | 2022-2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $179.79 | 2022-2023 | Iovera |
| Innovation Technologies INC | $163.80 | 2025 | Irrisept |
| Stryker Corporation | $160.71 | 2025 | Spy-Phi System |
| Acumed LLC | $157.93 | 2023 | Ribloc |
| Solventum Corporation | $153.29 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Tela Bio, INC. | $150.81 | 2022 | |
| Davol INC. | $141.32 | 2024 | Phasix Mesh |
| Medical Device Business Services, INC. | $138.87 | 2023 | |
| Abiomed | $133.35 | 2024 | Impella |
| Baxter Healthcare | $125.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Mallinckrodt Enterprises LLC | $124.99 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $118.89 | 2025 | Na |
| Covidien LP | $103.13 | 2019 | |
| W. L. Gore & Associates, INC. | $100.72 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Medline Industries LP | $99.82 | 2019 | |
| Mindray Ds USA, INC. | $90.54 | 2022-2025 | Te7 Max, Te X |
| Merck Sharp & Dohme LLC | $68.08 | 2019-2024 | Bridion |
| Medtronic, INC. | $47.29 | 2024-2025 | Becker, Shiley |
| Boston Scientific Corporation | $43.60 | 2022-2025 | Farapulse |
| Vyaire Medical, INC. | $38.48 | 2022 | |
| Medtronic Vascular, INC. | $38.39 | 2020 | |
| Masimo Corporation | $18.06 | 2021 | |
| Ambu INC. | $15.49 | 2021 | |
| Fujifilm Sonosite, INC. | $13.40 | 2023 | Sonosite Lx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Lorenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.